Alistair joined Palatine in February 2024 as a Partner in the investment team of the Impact Fund. Palatine’s Impact Fund is a returns-focused fund that partners with businesses which address significant environmental or social challenges. Alistair led Palatine’s investment in The Mole Clinic (providing skin cancer screening and procedures in the UK) in August 2024 and sits on the board of Isle (a global innovation consultancy specialising in the development and commercialisation of emerging technologies in the water and environmental sectors). Previously, Alistair worked at Primary Capital, lower-mid-market private equity investor with a strong focus on ESG since 2006 where he led a number of successful deals across multiple sectors. Alistair is an alumnus of the University of Oxford, where he studied mathematics, and has led various initiatives pioneering the use of data and AI for better investment decision making.